Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05366829 |
| Title | Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Rutgers, The State University of New Jersey |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Rutgers Cancer Institute of New Jersey | RECRUITING | New Brunswick | New Jersey | 08903 | United States | Details |
| Montefiore Medical Center | RECRUITING | Bronx | New York | 10451 | United States | Details |